

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | seminiferous tubule development (GO:0072520) | 9.28111019 |
| 2 | regulation of clathrin-mediated endocytosis (GO:2000369) | 7.01188172 |
| 3 | positive regulation of antigen processing and presentation (GO:0002579) | 6.01985271 |
| 4 | production of molecular mediator involved in inflammatory response (GO:0002532) | 5.81419484 |
| 5 | regulation of T cell tolerance induction (GO:0002664) | 5.65232081 |
| 6 | positive regulation of tolerance induction (GO:0002645) | 5.50478922 |
| 7 | fusion of sperm to egg plasma membrane (GO:0007342) | 5.24585201 |
| 8 | regulation of acrosome reaction (GO:0060046) | 5.22125767 |
| 9 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 4.85230700 |
| 10 | L-serine transport (GO:0015825) | 4.73316993 |
| 11 | regulation of tolerance induction (GO:0002643) | 4.69739645 |
| 12 | regulation of antigen processing and presentation (GO:0002577) | 4.61563705 |
| 13 | ribosomal small subunit assembly (GO:0000028) | 4.39555129 |
| 14 | complement activation, alternative pathway (GO:0006957) | 4.34223847 |
| 15 | kynurenine metabolic process (GO:0070189) | 4.31714580 |
| 16 | serine transport (GO:0032329) | 4.18750918 |
| 17 | viral transcription (GO:0019083) | 4.16689934 |
| 18 | regulation of chronic inflammatory response (GO:0002676) | 4.12757611 |
| 19 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.05893222 |
| 20 | translational termination (GO:0006415) | 3.97264475 |
| 21 | negative regulation of phagocytosis (GO:0050765) | 3.97060584 |
| 22 | sulfur amino acid catabolic process (GO:0000098) | 3.93064614 |
| 23 | valine metabolic process (GO:0006573) | 3.90184991 |
| 24 | respiratory burst (GO:0045730) | 3.89451711 |
| 25 | plasma membrane fusion (GO:0045026) | 3.86992158 |
| 26 | regulation of Cdc42 GTPase activity (GO:0043088) | 3.85260366 |
| 27 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.78141526 |
| 28 | positive regulation of mast cell degranulation (GO:0043306) | 3.78141526 |
| 29 | positive regulation of histone deacetylation (GO:0031065) | 3.74994136 |
| 30 | sperm capacitation (GO:0048240) | 3.60645533 |
| 31 | negative regulation of endopeptidase activity (GO:0010951) | 3.59265968 |
| 32 | pentose-phosphate shunt (GO:0006098) | 3.55418193 |
| 33 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.51979740 |
| 34 | cotranslational protein targeting to membrane (GO:0006613) | 3.49372092 |
| 35 | protein targeting to ER (GO:0045047) | 3.46281135 |
| 36 | COPI coating of Golgi vesicle (GO:0048205) | 3.44671331 |
| 37 | Golgi transport vesicle coating (GO:0048200) | 3.44671331 |
| 38 | translational elongation (GO:0006414) | 3.44578787 |
| 39 | alpha-linolenic acid metabolic process (GO:0036109) | 3.44117830 |
| 40 | negative regulation of peptidase activity (GO:0010466) | 3.40370466 |
| 41 | B cell receptor signaling pathway (GO:0050853) | 3.35969363 |
| 42 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.31620799 |
| 43 | response to misfolded protein (GO:0051788) | 3.24665838 |
| 44 | positive regulation of leukocyte degranulation (GO:0043302) | 3.22454620 |
| 45 | protein localization to endoplasmic reticulum (GO:0070972) | 3.21047233 |
| 46 | NADPH regeneration (GO:0006740) | 3.19496713 |
| 47 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.18079642 |
| 48 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.10436746 |
| 49 | triglyceride catabolic process (GO:0019433) | 3.10164601 |
| 50 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 3.06820315 |
| 51 | positive regulation of B cell differentiation (GO:0045579) | 3.04754982 |
| 52 | viral life cycle (GO:0019058) | 3.04123347 |
| 53 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.03044605 |
| 54 | protein complex disassembly (GO:0043241) | 3.01210840 |
| 55 | positive regulation of mast cell activation (GO:0033005) | 3.01033738 |
| 56 | ethanol oxidation (GO:0006069) | 3.00673682 |
| 57 | negative regulation of endocytosis (GO:0045806) | 2.98976949 |
| 58 | cellular protein complex disassembly (GO:0043624) | 2.97629983 |
| 59 | oxaloacetate metabolic process (GO:0006107) | 2.95377080 |
| 60 | low-density lipoprotein particle clearance (GO:0034383) | 2.94715124 |
| 61 | negative regulation of protein autophosphorylation (GO:0031953) | 2.89992879 |
| 62 | response to nitrosative stress (GO:0051409) | 2.88744056 |
| 63 | positive regulation of protein deacetylation (GO:0090312) | 2.85041940 |
| 64 | adaptation of signaling pathway (GO:0023058) | 2.84964558 |
| 65 | negative regulation of metanephros development (GO:0072217) | 2.84784185 |
| 66 | single fertilization (GO:0007338) | 2.82783857 |
| 67 | negative regulation of interleukin-10 production (GO:0032693) | 2.81217217 |
| 68 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.79842650 |
| 69 | cellular sodium ion homeostasis (GO:0006883) | 2.79257022 |
| 70 | ribosomal small subunit biogenesis (GO:0042274) | 2.79125864 |
| 71 | neutral lipid catabolic process (GO:0046461) | 2.76972956 |
| 72 | acylglycerol catabolic process (GO:0046464) | 2.76972956 |
| 73 | white fat cell differentiation (GO:0050872) | 2.75971324 |
| 74 | brown fat cell differentiation (GO:0050873) | 2.75705748 |
| 75 | L-serine metabolic process (GO:0006563) | 2.69680969 |
| 76 | macromolecular complex disassembly (GO:0032984) | 2.66881239 |
| 77 | cellular extravasation (GO:0045123) | 2.65766705 |
| 78 | heterotypic cell-cell adhesion (GO:0034113) | 2.65469155 |
| 79 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.65255515 |
| 80 | tryptophan catabolic process (GO:0006569) | 2.63064031 |
| 81 | indole-containing compound catabolic process (GO:0042436) | 2.63064031 |
| 82 | indolalkylamine catabolic process (GO:0046218) | 2.63064031 |
| 83 | positive regulation of receptor biosynthetic process (GO:0010870) | 2.61996690 |
| 84 | translational initiation (GO:0006413) | 2.60742455 |
| 85 | macroautophagy (GO:0016236) | 2.60431317 |
| 86 | natural killer cell differentiation (GO:0001779) | 2.58755565 |
| 87 | negative regulation of granulocyte differentiation (GO:0030853) | 2.55100403 |
| 88 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.52433572 |
| 89 | GPI anchor biosynthetic process (GO:0006506) | 2.52418068 |
| 90 | positive regulation of lamellipodium assembly (GO:0010592) | 2.50709811 |
| 91 | benzene-containing compound metabolic process (GO:0042537) | 2.49522378 |
| 92 | hypotonic response (GO:0006971) | 2.47611171 |
| 93 | mannose metabolic process (GO:0006013) | 2.45852156 |
| 94 | negative regulation of proteolysis (GO:0045861) | 2.45464075 |
| 95 | phospholipid homeostasis (GO:0055091) | 2.45272884 |
| 96 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 16.9130351 |
| 97 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 16.9130351 |
| 98 | antigen processing and presentation via MHC class Ib (GO:0002475) | 14.4975009 |
| 99 | antigen processing and presentation of endogenous antigen (GO:0019883) | 14.0779607 |
| 100 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 12.4717317 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA1_22025678_ChIP-Seq_K562_Human | 9.78317540 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.51177354 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.20996496 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 3.28267517 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.16991971 |
| 6 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.85389645 |
| 7 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.63869017 |
| 8 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.60499130 |
| 9 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.40995355 |
| 10 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.33775224 |
| 11 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.19875533 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.14233505 |
| 13 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.11288102 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.11243348 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.08866733 |
| 16 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.07278060 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.02806326 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.88107018 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.85396306 |
| 20 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.83792168 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.82904573 |
| 22 | UTX_26944678_Chip-Seq_JUKART_Human | 1.76739855 |
| 23 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.75039882 |
| 24 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.74637994 |
| 25 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.74159635 |
| 26 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.70554274 |
| 27 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.70468611 |
| 28 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.69039192 |
| 29 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.67230936 |
| 30 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.63786890 |
| 31 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.62106040 |
| 32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61936499 |
| 33 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.60245344 |
| 34 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.50275862 |
| 35 | MYB_26560356_Chip-Seq_TH2_Human | 1.48645699 |
| 36 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.46628691 |
| 37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.44846266 |
| 38 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.43480493 |
| 39 | MAF_26560356_Chip-Seq_TH1_Human | 1.40700711 |
| 40 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.39748597 |
| 41 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.38943203 |
| 42 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.38778308 |
| 43 | MYB_26560356_Chip-Seq_TH1_Human | 1.37228243 |
| 44 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.36956037 |
| 45 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.34444083 |
| 46 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.34384469 |
| 47 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.34304745 |
| 48 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.33074621 |
| 49 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.32179460 |
| 50 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.31822056 |
| 51 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.29223353 |
| 52 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.28740861 |
| 53 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.27172930 |
| 54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.25423516 |
| 55 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.22951391 |
| 56 | P68_20966046_ChIP-Seq_HELA_Human | 1.22146633 |
| 57 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.21793685 |
| 58 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.19582003 |
| 59 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.18510387 |
| 60 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.16565843 |
| 61 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.15424933 |
| 62 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15411224 |
| 63 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.13603505 |
| 64 | MYC_19915707_ChIP-ChIP_AK7_Human | 1.11436133 |
| 65 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.08774958 |
| 66 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.07557433 |
| 67 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06801571 |
| 68 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.06752761 |
| 69 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.05239764 |
| 70 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.04871660 |
| 71 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04815602 |
| 72 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04549764 |
| 73 | P300_27268052_Chip-Seq_Bcells_Human | 1.04468331 |
| 74 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.03589362 |
| 75 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00251789 |
| 76 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00215371 |
| 77 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.99986846 |
| 78 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.99805148 |
| 79 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.99612790 |
| 80 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.98439485 |
| 81 | GATA1_19941826_ChIP-Seq_K562_Human | 0.96835909 |
| 82 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.95207271 |
| 83 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.95027382 |
| 84 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.94250108 |
| 85 | SPI1_23127762_ChIP-Seq_K562_Human | 0.94008190 |
| 86 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.93625163 |
| 87 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.93493767 |
| 88 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90626975 |
| 89 | MAF_26560356_Chip-Seq_TH2_Human | 0.90186227 |
| 90 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.86052263 |
| 91 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.85961644 |
| 92 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.85539199 |
| 93 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.85237133 |
| 94 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84971412 |
| 95 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83432428 |
| 96 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.83061883 |
| 97 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.81757661 |
| 98 | GATA3_26560356_Chip-Seq_TH2_Human | 0.81304454 |
| 99 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.81112478 |
| 100 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.80900753 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.08599917 |
| 2 | MP0003300_gastrointestinal_ulcer | 3.53385204 |
| 3 | MP0003303_peritoneal_inflammation | 3.47974242 |
| 4 | MP0000685_abnormal_immune_system | 3.02054357 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 2.97344556 |
| 6 | MP0002396_abnormal_hematopoietic_system | 2.72687993 |
| 7 | MP0005670_abnormal_white_adipose | 2.48976445 |
| 8 | MP0010234_abnormal_vibrissa_follicle | 2.42016195 |
| 9 | MP0005666_abnormal_adipose_tissue | 2.19617303 |
| 10 | MP0004130_abnormal_muscle_cell | 2.17918019 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.09731580 |
| 12 | MP0005375_adipose_tissue_phenotype | 2.04873271 |
| 13 | MP0002166_altered_tumor_susceptibility | 2.02621703 |
| 14 | MP0004185_abnormal_adipocyte_glucose | 2.00483085 |
| 15 | MP0010352_gastrointestinal_tract_polyps | 1.99636718 |
| 16 | MP0003436_decreased_susceptibility_to | 1.99489987 |
| 17 | MP0001800_abnormal_humoral_immune | 1.98613792 |
| 18 | MP0005464_abnormal_platelet_physiology | 1.94181177 |
| 19 | MP0001545_abnormal_hematopoietic_system | 1.87446496 |
| 20 | MP0005397_hematopoietic_system_phenotyp | 1.87446496 |
| 21 | MP0001853_heart_inflammation | 1.83302817 |
| 22 | MP0000003_abnormal_adipose_tissue | 1.71018973 |
| 23 | MP0010329_abnormal_lipoprotein_level | 1.68690996 |
| 24 | MP0002452_abnormal_antigen_presenting | 1.66360002 |
| 25 | MP0005360_urolithiasis | 1.66045106 |
| 26 | MP0001661_extended_life_span | 1.64552978 |
| 27 | MP0002398_abnormal_bone_marrow | 1.60452220 |
| 28 | MP0000689_abnormal_spleen_morphology | 1.57106640 |
| 29 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56813756 |
| 30 | MP0001835_abnormal_antigen_presentation | 1.56625220 |
| 31 | MP0004808_abnormal_hematopoietic_stem | 1.56220001 |
| 32 | MP0001819_abnormal_immune_cell | 1.50041735 |
| 33 | MP0004947_skin_inflammation | 1.49615927 |
| 34 | MP0002420_abnormal_adaptive_immunity | 1.47033877 |
| 35 | MP0001790_abnormal_immune_system | 1.42511082 |
| 36 | MP0005387_immune_system_phenotype | 1.42511082 |
| 37 | MP0006054_spinal_hemorrhage | 1.40662722 |
| 38 | MP0000716_abnormal_immune_system | 1.39502748 |
| 39 | MP0002722_abnormal_immune_system | 1.36767378 |
| 40 | MP0003566_abnormal_cell_adhesion | 1.35021743 |
| 41 | MP0009643_abnormal_urine_homeostasis | 1.33002978 |
| 42 | MP0002723_abnormal_immune_serum | 1.32005259 |
| 43 | MP0008961_abnormal_basal_metabolism | 1.29113983 |
| 44 | MP0002006_tumorigenesis | 1.28840392 |
| 45 | MP0003195_calcinosis | 1.27644826 |
| 46 | MP0002970_abnormal_white_adipose | 1.24421609 |
| 47 | MP0009278_abnormal_bone_marrow | 1.23327637 |
| 48 | MP0003705_abnormal_hypodermis_morpholog | 1.21641749 |
| 49 | MP0001765_abnormal_ion_homeostasis | 1.21072861 |
| 50 | MP0002429_abnormal_blood_cell | 1.19310319 |
| 51 | MP0005334_abnormal_fat_pad | 1.18874073 |
| 52 | MP0003656_abnormal_erythrocyte_physiolo | 1.18398869 |
| 53 | MP0004043_abnormal_pH_regulation | 1.18219816 |
| 54 | MP0003075_altered_response_to | 1.17608736 |
| 55 | MP0009115_abnormal_fat_cell | 1.17103535 |
| 56 | MP0001501_abnormal_sleep_pattern | 1.14645016 |
| 57 | MP0005671_abnormal_response_to | 1.13606415 |
| 58 | MP0009763_increased_sensitivity_to | 1.11630111 |
| 59 | MP0000609_abnormal_liver_physiology | 1.11608011 |
| 60 | MP0002118_abnormal_lipid_homeostasis | 1.11036804 |
| 61 | MP0003866_abnormal_defecation | 1.10166294 |
| 62 | MP0009785_altered_susceptibility_to | 1.09166759 |
| 63 | MP0001533_abnormal_skeleton_physiology | 1.09151692 |
| 64 | MP0002136_abnormal_kidney_physiology | 1.07992912 |
| 65 | MP0001845_abnormal_inflammatory_respons | 1.07805393 |
| 66 | MP0002419_abnormal_innate_immunity | 1.06470739 |
| 67 | MP0002138_abnormal_hepatobiliary_system | 1.06052171 |
| 68 | MP0005025_abnormal_response_to | 1.05731339 |
| 69 | MP0005000_abnormal_immune_tolerance | 1.02479571 |
| 70 | MP0002971_abnormal_brown_adipose | 1.01337181 |
| 71 | MP0002148_abnormal_hypersensitivity_rea | 1.00129331 |
| 72 | MP0005365_abnormal_bile_salt | 0.99883767 |
| 73 | MP0001756_abnormal_urination | 0.96482773 |
| 74 | MP0000703_abnormal_thymus_morphology | 0.95294922 |
| 75 | MP0003724_increased_susceptibility_to | 0.95247543 |
| 76 | MP0010155_abnormal_intestine_physiology | 0.95033668 |
| 77 | MP0002909_abnormal_adrenal_gland | 0.94610681 |
| 78 | MP0009379_abnormal_foot_pigmentation | 0.94353745 |
| 79 | MP0005410_abnormal_fertilization | 0.93057701 |
| 80 | MP0003959_abnormal_lean_body | 0.92447240 |
| 81 | MP0003045_fibrosis | 0.90086260 |
| 82 | MP0005636_abnormal_mineral_homeostasis | 0.89640834 |
| 83 | MP0003646_muscle_fatigue | 0.88772030 |
| 84 | MP0002254_reproductive_system_inflammat | 0.83850137 |
| 85 | MP0008438_abnormal_cutaneous_collagen | 0.82654057 |
| 86 | MP0004036_abnormal_muscle_relaxation | 0.80797595 |
| 87 | MP0000598_abnormal_liver_morphology | 0.80404470 |
| 88 | MP0001764_abnormal_homeostasis | 0.80218312 |
| 89 | MP0005319_abnormal_enzyme/_coenzyme | 0.79525708 |
| 90 | MP0002796_impaired_skin_barrier | 0.76572908 |
| 91 | MP0000858_altered_metastatic_potential | 0.71991758 |
| 92 | MP0003183_abnormal_peptide_metabolism | 0.71760355 |
| 93 | MP0000604_amyloidosis | 0.70393092 |
| 94 | MP0003806_abnormal_nucleotide_metabolis | 0.70145219 |
| 95 | MP0000490_abnormal_crypts_of | 0.70124896 |
| 96 | MP0000249_abnormal_blood_vessel | 0.69797270 |
| 97 | MP0005166_decreased_susceptibility_to | 0.67650092 |
| 98 | MP0000477_abnormal_intestine_morphology | 0.67469200 |
| 99 | MP0003186_abnormal_redox_activity | 0.67438374 |
| 100 | MP0008469_abnormal_protein_level | 0.66459294 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Choroideremia (HP:0001139) | 5.95826845 |
| 2 | Abnormal rod and cone electroretinograms (HP:0008323) | 5.66932807 |
| 3 | Cellulitis (HP:0100658) | 5.55939888 |
| 4 | Abnormality of the fovea (HP:0000493) | 5.38366390 |
| 5 | Agammaglobulinemia (HP:0004432) | 5.37490668 |
| 6 | Complement deficiency (HP:0004431) | 5.00900551 |
| 7 | 11 pairs of ribs (HP:0000878) | 4.85744017 |
| 8 | Vacuolated lymphocytes (HP:0001922) | 4.84930426 |
| 9 | Metaphyseal cupping (HP:0003021) | 4.80771244 |
| 10 | Bony spicule pigmentary retinopathy (HP:0007737) | 4.69720667 |
| 11 | Chronic otitis media (HP:0000389) | 4.52106909 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.35094310 |
| 13 | Hypopigmentation of the fundus (HP:0007894) | 3.91296749 |
| 14 | Papilloma (HP:0012740) | 3.74262408 |
| 15 | Verrucae (HP:0200043) | 3.74262408 |
| 16 | Facial diplegia (HP:0001349) | 3.73832759 |
| 17 | Abnormality of complement system (HP:0005339) | 3.49129909 |
| 18 | Facial shape deformation (HP:0011334) | 3.26425560 |
| 19 | Potter facies (HP:0002009) | 3.26425560 |
| 20 | Recurrent bronchitis (HP:0002837) | 3.16653550 |
| 21 | Osteomyelitis (HP:0002754) | 3.15508629 |
| 22 | Stridor (HP:0010307) | 3.12125266 |
| 23 | Missing ribs (HP:0000921) | 3.11598199 |
| 24 | Thrombocytosis (HP:0001894) | 3.10845673 |
| 25 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.06198129 |
| 26 | Hand muscle atrophy (HP:0009130) | 3.05778947 |
| 27 | Abnormality of the calcaneus (HP:0008364) | 3.05071392 |
| 28 | Myocardial infarction (HP:0001658) | 2.88445801 |
| 29 | Vascular calcification (HP:0004934) | 2.81154434 |
| 30 | Small epiphyses (HP:0010585) | 2.77151919 |
| 31 | Autoimmune thrombocytopenia (HP:0001973) | 2.74904142 |
| 32 | Reticulocytopenia (HP:0001896) | 2.66131208 |
| 33 | IgM deficiency (HP:0002850) | 2.61710143 |
| 34 | Intention tremor (HP:0002080) | 2.60373221 |
| 35 | Abnormal number of erythroid precursors (HP:0012131) | 2.59866442 |
| 36 | Cardiovascular calcification (HP:0011915) | 2.53697065 |
| 37 | Chronic sinusitis (HP:0011109) | 2.41768365 |
| 38 | Recurrent viral infections (HP:0004429) | 2.41134820 |
| 39 | Upper limb amyotrophy (HP:0009129) | 2.40493472 |
| 40 | Distal upper limb amyotrophy (HP:0007149) | 2.40493472 |
| 41 | Increased density of long bones (HP:0006392) | 2.38824369 |
| 42 | Dysostosis multiplex (HP:0000943) | 2.35791185 |
| 43 | Cerebral inclusion bodies (HP:0100314) | 2.29060297 |
| 44 | Abnormal hemoglobin (HP:0011902) | 2.25807169 |
| 45 | Meningitis (HP:0001287) | 2.25243000 |
| 46 | Neurofibrillary tangles (HP:0002185) | 2.24826857 |
| 47 | Cutaneous melanoma (HP:0012056) | 2.23069864 |
| 48 | Abnormality of the lumbar spine (HP:0100712) | 2.21883742 |
| 49 | Sepsis (HP:0100806) | 2.18861283 |
| 50 | Hyperphosphatemia (HP:0002905) | 2.17903800 |
| 51 | Vertebral arch anomaly (HP:0008438) | 2.16480343 |
| 52 | Mitral stenosis (HP:0001718) | 2.15512098 |
| 53 | Hypertriglyceridemia (HP:0002155) | 2.12627573 |
| 54 | Gastrointestinal inflammation (HP:0004386) | 2.09232748 |
| 55 | Papilledema (HP:0001085) | 2.08747645 |
| 56 | Vertebral hypoplasia (HP:0008417) | 2.07961525 |
| 57 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.07961525 |
| 58 | Hyperglycinuria (HP:0003108) | 2.07669869 |
| 59 | Colitis (HP:0002583) | 2.01246640 |
| 60 | Supranuclear gaze palsy (HP:0000605) | 2.00676735 |
| 61 | Interstitial pulmonary disease (HP:0006530) | 2.00548943 |
| 62 | Ulnar bowing (HP:0003031) | 1.99941442 |
| 63 | Action tremor (HP:0002345) | 1.99903613 |
| 64 | Abnormality of macrophages (HP:0004311) | 1.99594081 |
| 65 | Abnormality of purine metabolism (HP:0004352) | 1.98481877 |
| 66 | Pallor (HP:0000980) | 1.96673625 |
| 67 | Prolonged bleeding time (HP:0003010) | 1.96220081 |
| 68 | Loss of speech (HP:0002371) | 1.95452888 |
| 69 | Diaphragmatic weakness (HP:0009113) | 1.94266774 |
| 70 | Neoplasm of the heart (HP:0100544) | 1.93361554 |
| 71 | Inflammation of the large intestine (HP:0002037) | 1.92808045 |
| 72 | Skin rash (HP:0000988) | 1.90234673 |
| 73 | Oligomenorrhea (HP:0000876) | 1.89567924 |
| 74 | Hematochezia (HP:0002573) | 1.89553319 |
| 75 | Pseudobulbar signs (HP:0002200) | 1.89380739 |
| 76 | Recurrent sinusitis (HP:0011108) | 1.88129552 |
| 77 | Abnormality of the nasal mucosa (HP:0000433) | 1.87368976 |
| 78 | Thyroiditis (HP:0100646) | 1.86575774 |
| 79 | Nasal polyposis (HP:0100582) | 1.84992463 |
| 80 | Slender build (HP:0001533) | 1.80655141 |
| 81 | Spastic diplegia (HP:0001264) | 1.80150894 |
| 82 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.77695593 |
| 83 | Short 4th metacarpal (HP:0010044) | 1.77695593 |
| 84 | Bronchitis (HP:0012387) | 1.77477501 |
| 85 | Abnormal platelet volume (HP:0011876) | 1.75805332 |
| 86 | Macroorchidism (HP:0000053) | 1.73184862 |
| 87 | Macrocytic anemia (HP:0001972) | 1.72724667 |
| 88 | Multiple enchondromatosis (HP:0005701) | 1.72432974 |
| 89 | Thoracic kyphosis (HP:0002942) | 1.72143614 |
| 90 | Hypoplasia of the thymus (HP:0000778) | 1.70098687 |
| 91 | Infantile muscular hypotonia (HP:0008947) | 1.69798598 |
| 92 | Acrocyanosis (HP:0001063) | 1.67999681 |
| 93 | Fatigue (HP:0012378) | 1.67826071 |
| 94 | Aortic aneurysm (HP:0004942) | 1.67445046 |
| 95 | Hemiplegia (HP:0002301) | 1.67361248 |
| 96 | Abnormality of glycine metabolism (HP:0010895) | 1.67092769 |
| 97 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.67092769 |
| 98 | Mucopolysacchariduria (HP:0008155) | 1.65582988 |
| 99 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.65582988 |
| 100 | Ankle clonus (HP:0011448) | 1.64634964 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EEF2K | 6.36779546 |
| 2 | PKN2 | 4.42001651 |
| 3 | ERN1 | 3.84074581 |
| 4 | MAP3K10 | 3.69581389 |
| 5 | TAOK3 | 2.99809345 |
| 6 | LRRK2 | 2.76603549 |
| 7 | TRIB3 | 2.60100491 |
| 8 | SIK2 | 2.38812041 |
| 9 | SIK1 | 2.24560527 |
| 10 | FRK | 2.20709124 |
| 11 | LMTK2 | 2.11605136 |
| 12 | CLK1 | 2.05331328 |
| 13 | GRK6 | 2.03152376 |
| 14 | RPS6KB2 | 2.01174119 |
| 15 | STK10 | 1.92951041 |
| 16 | FLT3 | 1.88857886 |
| 17 | RIPK4 | 1.86312600 |
| 18 | MAP4K1 | 1.84727208 |
| 19 | MST4 | 1.70016377 |
| 20 | FGFR2 | 1.62428556 |
| 21 | MYLK | 1.61892483 |
| 22 | SCYL2 | 1.56662841 |
| 23 | BTK | 1.56033932 |
| 24 | NEK2 | 1.53354378 |
| 25 | SYK | 1.45530523 |
| 26 | FES | 1.45323884 |
| 27 | PAK2 | 1.43118212 |
| 28 | MAPKAPK3 | 1.40874140 |
| 29 | CDK19 | 1.23428843 |
| 30 | BLK | 1.19650877 |
| 31 | CSF1R | 1.17580417 |
| 32 | MAPK11 | 1.15456056 |
| 33 | MAPK12 | 1.14096221 |
| 34 | TNK2 | 1.07354133 |
| 35 | TGFBR1 | 1.04398082 |
| 36 | BMX | 0.96279895 |
| 37 | TTK | 0.91162473 |
| 38 | PASK | 0.89372054 |
| 39 | CDK6 | 0.88802745 |
| 40 | RET | 0.82703797 |
| 41 | CAMK1D | 0.81580816 |
| 42 | FGFR3 | 0.81037545 |
| 43 | MAP3K8 | 0.77163065 |
| 44 | RIPK1 | 0.76579622 |
| 45 | TEC | 0.75139551 |
| 46 | LYN | 0.74958457 |
| 47 | ITK | 0.74161669 |
| 48 | JAK2 | 0.73913682 |
| 49 | ILK | 0.73645124 |
| 50 | CAMK1G | 0.72634345 |
| 51 | CDK4 | 0.71072392 |
| 52 | HIPK2 | 0.70851208 |
| 53 | RPS6KB1 | 0.69312629 |
| 54 | MAP3K12 | 0.68286714 |
| 55 | MAP3K7 | 0.64279303 |
| 56 | MAPK4 | 0.64160869 |
| 57 | EPHB1 | 0.63288309 |
| 58 | ALK | 0.63173799 |
| 59 | WNK1 | 0.62419516 |
| 60 | PRKCH | 0.61445710 |
| 61 | PDK1 | 0.57659450 |
| 62 | STK3 | 0.56912628 |
| 63 | TTN | 0.54991949 |
| 64 | MAPKAPK2 | 0.54755556 |
| 65 | STK4 | 0.54554466 |
| 66 | FGFR4 | 0.54491917 |
| 67 | LCK | 0.53834087 |
| 68 | TGFBR2 | 0.50851816 |
| 69 | TYK2 | 0.48196282 |
| 70 | PTK6 | 0.47318164 |
| 71 | IRAK3 | 0.46996100 |
| 72 | MATK | 0.45176673 |
| 73 | CAMK1 | 0.43598189 |
| 74 | JAK3 | 0.43356248 |
| 75 | KIT | 0.42728824 |
| 76 | MAPK13 | 0.42454782 |
| 77 | PDK3 | 0.40907957 |
| 78 | PDK4 | 0.40907957 |
| 79 | EGFR | 0.40728835 |
| 80 | WNK4 | 0.40725266 |
| 81 | JAK1 | 0.40676910 |
| 82 | PDGFRA | 0.39737012 |
| 83 | FYN | 0.38923982 |
| 84 | HCK | 0.37420922 |
| 85 | SRC | 0.34890135 |
| 86 | BCKDK | 0.34888973 |
| 87 | PIK3CG | 0.31921776 |
| 88 | RPS6KA4 | 0.31481855 |
| 89 | MTOR | 0.30850523 |
| 90 | ATR | 0.30413602 |
| 91 | DAPK1 | 0.29925334 |
| 92 | PRKD1 | 0.28243246 |
| 93 | PAK4 | 0.27683000 |
| 94 | TBK1 | 0.27668411 |
| 95 | INSR | 0.24430306 |
| 96 | MAPK3 | 0.24294696 |
| 97 | DYRK1B | 0.23200412 |
| 98 | KSR2 | 0.19936608 |
| 99 | ZAP70 | 0.19542263 |
| 100 | EIF2AK3 | 0.17840701 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.68899310 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.47943612 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.39785034 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.39755721 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.37780283 |
| 6 | ABC transporters_Homo sapiens_hsa02010 | 2.33872814 |
| 7 | Ribosome_Homo sapiens_hsa03010 | 2.33670711 |
| 8 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.29861329 |
| 9 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.25986856 |
| 10 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.25860583 |
| 11 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.24334930 |
| 12 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 2.23135437 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.16702010 |
| 14 | Glutathione metabolism_Homo sapiens_hsa00480 | 2.14401201 |
| 15 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.12994973 |
| 16 | Asthma_Homo sapiens_hsa05310 | 2.12938308 |
| 17 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.07813435 |
| 18 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.92052569 |
| 19 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.62936681 |
| 20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.57026050 |
| 21 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.51353253 |
| 22 | Salivary secretion_Homo sapiens_hsa04970 | 1.51171113 |
| 23 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.32646044 |
| 24 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.31193012 |
| 25 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.30111464 |
| 26 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.25306622 |
| 27 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.21982477 |
| 28 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.14046451 |
| 29 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.13405521 |
| 30 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11513539 |
| 31 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.11096623 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.10576013 |
| 33 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.09661188 |
| 34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.07705665 |
| 35 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.07050315 |
| 36 | Glioma_Homo sapiens_hsa05214 | 1.03575811 |
| 37 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.01553151 |
| 38 | Platelet activation_Homo sapiens_hsa04611 | 1.01274797 |
| 39 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.00565070 |
| 40 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.99590812 |
| 41 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.97459961 |
| 42 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.94746111 |
| 43 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.93503911 |
| 44 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.92751173 |
| 45 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.91577521 |
| 46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.90743482 |
| 47 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.90558669 |
| 48 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.90073054 |
| 49 | Insulin resistance_Homo sapiens_hsa04931 | 0.85527297 |
| 50 | Lysosome_Homo sapiens_hsa04142 | 0.83596154 |
| 51 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.82113159 |
| 52 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.79041677 |
| 53 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.78349162 |
| 54 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.75475750 |
| 55 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.71552518 |
| 56 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.71272831 |
| 57 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.70824528 |
| 58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.70553815 |
| 59 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.70205077 |
| 60 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.68100991 |
| 61 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.66421870 |
| 62 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.66016091 |
| 63 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.65650309 |
| 64 | Renin secretion_Homo sapiens_hsa04924 | 0.65069295 |
| 65 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.64978372 |
| 66 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.64378352 |
| 67 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.62250975 |
| 68 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.61447300 |
| 69 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.60958409 |
| 70 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.60764857 |
| 71 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57923034 |
| 72 | Leishmaniasis_Homo sapiens_hsa05140 | 0.57862151 |
| 73 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.57543638 |
| 74 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.56310133 |
| 75 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54974556 |
| 76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.54570195 |
| 77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53408248 |
| 78 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.52825083 |
| 79 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.51811267 |
| 80 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.51479915 |
| 81 | Prion diseases_Homo sapiens_hsa05020 | 0.50345651 |
| 82 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.49367306 |
| 83 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.49250532 |
| 84 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.46360784 |
| 85 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.45463718 |
| 86 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.44450930 |
| 87 | Peroxisome_Homo sapiens_hsa04146 | 0.44122289 |
| 88 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.43535547 |
| 89 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.41036008 |
| 90 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.40631570 |
| 91 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.39742283 |
| 92 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.34001838 |
| 93 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.33760739 |
| 94 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.33693440 |
| 95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.31535183 |
| 96 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.31240248 |
| 97 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.30400916 |
| 98 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.28690409 |
| 99 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.27858955 |
| 100 | Base excision repair_Homo sapiens_hsa03410 | 0.27832569 |

